NZ sharemarket gains 1% thanks to F&P Healthcare
In a familiar pattern, the S&P/NZX 50 Index bounced at lunchtime and traded strongly in the afternoon to close at 11,916.24, up 111.15 points or 0.94%.
There were 84 gainers and 56 decliners on the main board, with 31.62 million shares worth $123.2m changing hands.
Market leader Fisher and Paykel Healthcare increased 59c or 2.15% to $27.99 on trade worth $34.35m, spurred on by a strong quarterly result from competitor ResMed, established in Australia but now based in San Diego. Fisher and Paykel sat at $28 on Jan 24, 2022.
ResMed was up 3.44%to A$32.58, following Friday’s rise of 9.6%, on the Australian exchange, with the S&P/ASX 200 Index having gained 0.677% to 7,634.6 points at 6pm NZ time.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.
![[The Wrap] What the heck is happening at the FMA?](https://goodreturns.publit.io/file/c_fill,w_300,h_200/a6c3bc06-6401-44de-96e2-286c090e132d.jpg)
